| PROMIS NEUROSCIENCES |
| Kanada |
| Gesundheit |
| CA74346M5054 / A41MFQ |
| 23J (Frankfurt) / PMN (NASDAQ) |
| FRA:23J, ETR:23J, 23J:GR, NASDAQ:PMN |
| - |
| https://www.promisneurosc.. |
|
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective ..
>Volltext.. |
| 24.24 Mio. EUR |
| 19.01 Mio. EUR |
| - |
| -34.8 Mio. EUR |
| -34.41 Mio. EUR |
| -20.29 EUR |
| - |
| 5.3 Mio. EUR |
| -24.41 Mio. EUR |
| 0.59 |
| - |
| -1359.82% |
| - |
| - |
| - |
| PROMIS NEUROSCIENCES, PROMIS NEURO |
| 05.04.26 |